fluorine F 18 EF5

Known as: 18F-EF5, F18-EF5 
A radioconjugate consisting of EF5, a fluorinated derivative of etanidazole, conjugated to fluorine F 18, a positron emitting isotope. EF5 binds to… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2015
01220022015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
We evaluated the relationship between pre-treatment positron emission tomography (PET) using the hypoxic tracer 18F-[2-(2-nitro-1… (More)
Is this relevant?
2013
2013
UNLABELLED Hypoxia is a significant therapeutic problem for solid tumors because hypoxic cells are treatment-resistant and more… (More)
Is this relevant?
2010
2010
The primary purpose of this study was to assess the biodistribution and radiation dose resulting from administration of 18F-EF5… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2010
Review
2010
Fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) is utilized in more than 90% of cancers in staging, re-staging… (More)
Is this relevant?
2008
2008
UNLABELLED The aim of this study was to evaluate 2-(2-nitro-(1)H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)-acetamide (EF5… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
OBJECTIVE To evaluate hypoxia non-invasively in androgen-dependent (AD), regressing (6-days after castration, RG) and androgen… (More)
Is this relevant?
2004
2004
no. Country Author Radiopharmaceutical Title 1106–326 Germany Kreissl 18F-FES and 18F-FTX Visualization of sex hormone and SERM… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Tumor hypoxia is an important prognostic indicator for cancer therapy outcome. EF5 {2-(2-nitro-1[H]-imidazol-1-yl)-N-(2,2,3,3,3… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • table 1
Is this relevant?